Jerusalem : Israeli Defence Minister Israel Katz said Wednesday that Israeli forces will remain in Gaza and maintain “security control” over the Palestinian territory, raising concerns that the latest round of ceasefire talks may face further deadlock. During a visit to a buffer zone along the Gaza-Egypt border, Katz said “security control in Gaza will remain in the hands of the IDF (Israel Defense Forces).” He stated that Israeli forces would remain in “security zones, buffer areas, and control positions” within the Gaza Strip, describing the measure as necessary “to ensure the safety of (Israeli) communities.” “There will be no Hamas government here, nor a Hamas military — a new reality will emerge thanks to the ongoing fighting,” Katz added. The minister’s comments came shortly after Israeli Prime Minister Benjamin Netanyahu’s office and Hamas accused each other of delays in reaching a Gaza ceasefire agreement, each claiming the other had introduced new demands. A key demand by Hamas has been an Israeli withdrawal from the enclave, which has been devastated by Israel’s heavy bombardment and airstrikes. In a press statement, Hamas said the talks in Doha, mediated by Qatar and Egypt, were “progressing seriously.” However, it accused Israel of introducing “new conditions related to the issues of the withdrawal (from Gaza), the ceasefire, the prisoners, and the return of the displaced people.” These conditions, Hamas claimed, caused “the delay in reaching an agreement that was within reach.” In response, Israeli Prime Minister Benjamin Netanyahu’s office released a statement denying Hamas’s accusations. The statement said Hamas had backtracked on understandings already reached and was “hindering the negotiations” On Tuesday, Israel recalled its delegation from the talks in Doha, stating that the team had been involved in a week of “meaningful” discussions. “The team is returning for internal consultations in Israel regarding the continuation of negotiations for the return of our hostages,” the office said, Xinhua news agency reported. The team included senior officials from the Mossad, Shin Bet security agency, and the Israel Defense Forces (IDF). The withdrawal of the Israeli forces from the coastal Palestinian enclave and the length of the ceasefire have been key sticking points in previous failed negotiation attempts. Hamas seeks to end the war entirely, while Israel insists on removing Hamas’ control over Gaza before any resolution and maintaining a military presence in the Palestinian enclave even after the ceasefire. On Monday, Israeli Prime Minister Benjamin Netanyahu had said that “there has been progress” in efforts to secure a ceasefire-for-hostages deal with Hamas, but cautioned that the timeline for reaching an agreement remains unclear. Speaking before the Knesset, the Israeli parliament, Netanyahu said, “I do not know how long it will take,” while vowing to “continue to act in every possible way until we bring everyone home.” Foreign Minister Gideon Saar also outlined parts of the deal during a closed meeting of the Knesset Foreign Affairs and Defence Committee, describing it as “a phased, gradual framework.” Israel’s Diaspora Minister Amichai Chikli told Kan Reshet Bet public radio that there had been “some” progress toward an agreement, adding that the sides are closer to a deal than in recent months. He said the initial phase would be “a humanitarian phase,” involving a 42-day ceasefire and the release of some hostages. “This ceasefire could last six months or 10 years, depending on the dynamics that develop on the ground,” Chikli said. Israel has been conducting a large-scale offensive against Hamas in the Gaza Strip to retaliate against a Hamas rampage through the southern Israeli border on October 7, 2023, during which about 1200 people were killed and about 250 taken hostage.
On Monday, U.S. Senators Dick Durbin and Tammy Duckworth announced that the U.S. Department of Energy's Bioenergy Technologies Office is awarding the University of Illinois $10 million in federal funding. That money, says crop sciences Professor DoKyoung Lee, will help take studies on "purpose-grown energy crops" to the next level to prove that the science works on a large scale. Lee said that official term, "purpose-grown energy crop," means pretty much exactly what it sounds like when you break it down: crops that have the necessary components to be good for creating fuel and are grown specifically for that purpose, not for food or anything else. Most people are already familiar with the concept of corn being used to create ethanol to power cars, but UI researchers are looking at crops that can create fuel to power airplanes. Lee said this is important in creating sustainability across the transportation industry. "By 2035-40, we are expecting pretty much all passenger and small fleet vehicles to use electricity or hydrogen or something like that," Lee said. "But an airplane cannot run by a battery. Maybe in the future we'll have a completely different form of a battery and it won't be a problem, but especially going continent-to-continent, long-distance flights, it's obviously not going to be batteries." Using plants to make fuel would be more environmentally friendly than using fossil fuels, and would make the United States more energy-independent. Different plants can be used to make different kinds of fuel, but Lee said that many of those used in jet fuel are already native to Illinois and the Midwest, which means they would also be healthy for the local ecosystem. Miscanthus and switchgrass sequester carbon from the atmosphere and can be produced on land that isn't suitable for annual production of crops like corn and soybeans, Lee said. Lee and other UI researchers have been working with these plants for some time to understand how they can be used to make fuel, but this $10 million grant will allow them to begin expanding tests. He said the plan is to plant energy crops across many acres and harvest them with large-scale machinery to begin understanding large-scale production. "It's basically exactly the same as what farmers are going to do," Lee said. "We are trying to see how this crop can help farmers' revenue generation while farmers can provide the biggest step for sustainable aviation fuel production and at the same time, they can provide another benefit to society and our environment."
PLYMOUTH MEETING, Pa. , Dec. 12, 2024 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO ), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock, in an underwritten public offering. All of the securities in the proposed offering will be sold by INOVIO. The proposed offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. Oppenheimer & Co. Inc. and Citizens JMP are acting as joint book-running managers for the offering. Stephens Inc. is acting as lead manager for the offering. A shelf registration statement relating to the shares of common stock and accompanying warrants offered in the offering described above was filed with the Securities and Exchange Commission (SEC) on November 9, 2023 and declared effective by the SEC on January 31, 2024 . The offering will be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to and describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov . Copies of the preliminary prospectus supplement and the accompanying prospectus, when available, may also be obtained by contacting: Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, NY 10004, by telephone at (212) 667-8055, or by email at [email protected] ; or Citizens JMP Securities, LLC, 600 Montgomery Street, Suite 1100, San Francisco, California 94111, by telephone at (415) 835-8985, or by email at [email protected] . This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About INOVIO INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. Forward-Looking Statements This release contains or may imply "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not based on historical fact and include, but are not limited to, statements regarding INOVIO's anticipated public offering, including the completion of the public offering on the anticipated terms, if at all. Any forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties related to market conditions and satisfaction of customary closing conditions related to the proposed public offering. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in INOVIO's Annual Report on Form 10-K for the year ended December 31, 2023 , INOVIO's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and in other filings that INOVIO makes with the SEC from time to time. There can be no assurance that any of the forward-looking information provided herein will be proven accurate. These forward-looking statements speak only as of the date hereof and INOVIO undertakes no obligation to update forward-looking statements, and readers are cautioned not to place undue reliance on such forward-looking statements. Contacts Media: Jennie Willson (267) 429-8567 [email protected] Investors: Peter Vozzo , ICR Healthcare, 443-213-0505 [email protected] SOURCE INOVIO Pharmaceuticals, Inc.
30th Palmolive Sindh Women’s Swimming Championship 2024AUSTIN, Texas , Dec. 12, 2024 /PRNewswire/ -- As the nurse practitioner (NP) profession looks ahead to 2025, the American Association of Nurse Practitioners® (AANP) has identified five key health trends that will impact the health care system in the coming years. "As health care trends evolve, the demand for America's 385,000 licensed nurse practitioners remains high due to their exceptional, patient-centered approach to care," said AANP President Stephen A. Ferrara , DNP. "Patients nationwide deserve access to high-quality health care, and NPs are experts in various fields, including primary care, elder care, mental health care, substance use disorder treatment and artificial intelligence (AI) innovations. Nurse practitioners are dedicated to providing evidence-based care as the health care landscape continues to change." The Top Five Health Care Trends of 2025 1. AI Technologies Can Improve Patient Care – Nurse practitioners are leading the way to improve health care access and outcomes for millions of patients and leveraging the potential of new technologies, including AI, to benefit their patients. In their constant pursuit of excellence in health care, NPs are exploring the capability of AI to analyze vast amounts of patient data from remote monitoring devices to allow more proactive interventions and added patient engagement in care. The potential for AI to automate non-clinical routine tasks, like note-taking and documentation, will allow NPs and other providers to focus even more on patient interactions. Used properly, AI can make a real difference while reducing documentation and administrative burdens. Nurse Practitioners are well-positioned to evaluate and guide the implementation of safe and effective AI technologies and must be actively involved throughout the entire AI development and integration process to improve patient outcomes. 2. Growing Demand for Elder Care – As the U.S. population ages, the rising demand for elder care requires a growing health care workforce. Every Baby Boomer will be at least 65 by 2030, with the oldest members closer to 85 – meaning 1 out of every 5 Americans will be eligible to enroll in Medicare. At the same time, the NP profession is 385,000 strong, ensuring needed access to care for patients. NPs provide care to seniors in a wide variety of settings, including telehealth and in - home care. 3. Mental Health Integration into Primary Care – NPs and other primary care providers are increasingly integrating patients' mental health into primary care screenings for both physical and mental health problems, during their visits. Mental health conditions have increased sharply since the COVID-19 pandemic, and more than 122 million people live in areas where access to treatment is limited due to provider shortages. With a strong focus on whole-patient care, NPs understand the important role mental health plays in the overall well-being of their patients. In addition, increasing numbers of psychiatric mental health nurse practitioners will play a vital role in meeting the nation's need for diagnosing, treating and managing mental health conditions. 4. Limited Access to Primary Care Services – More than a quarter of Americans reported they are not up to date on health screenings and immunizations, according to AANP's State of Primary Care in America national survey. The survey also found that nearly one-third of adults, particularly those who are younger, Hispanic or living in rural areas, reported difficulty accessing health care services. Among adults who did see a provider for primary care, nearly a third (31%) turned to telehealth or to convenient care clinics. This survey echoes AANP's 2023 survey, which found that more than 25% of respondents had waited more than two months for an appointment with a health care provider. Adopting Full Practice Authority policies removes barriers to care so patients can choose an NP to access preventive screenings and health services, which are essential to improving the health of the nation. 5. NPs Treating Patients with Substance Use Disorders – According to the National Institute on Drugs and Addiction's 2024 fact sheet, more than 40 million people in the United States had a substance use disorder (SUD), and only 6.5 percent received treatment. More than 100,000 people died from an overdose in 2021. NPs who specialize in SUD and opioid use disorder (OUD) treatment are experts in this addiction crisis, prescribing medications to aid in recovery and ensuring that their patients have access to counseling, behavioral therapy, peer support and other interventions. The American Association of Nurse Practitioners ® (AANP) is the largest professional membership organization for nurse practitioners (NPs) of all specialties. It represents the interests of the more than 385,000 licensed NPs in the U.S. AANP provides legislative leadership at the local, state and national levels, advancing health policy; promoting excellence in practice, education and research; and establishing standards that best serve NPs' patients and other health care consumers. As The Voice of the Nurse Practitioner ® , AANP represents the interests of NPs as providers of high-quality, cost-effective, comprehensive, patient-centered health care. To locate an NP in your community, visit npfinder.com . For more information about NPs, visit aanp.org . View original content to download multimedia: https://www.prnewswire.com/news-releases/aanp-spotlights-five-critical-health-care-trends-to-watch-in-2025-302330746.html SOURCE American Association of Nurse Practitioners (AANP)
AANP Spotlights Five Critical Health Care Trends to Watch in 2025New Player in the Market Will It Surpass Dogecoin’s Widespread Fame?
( ) and startup Anduril are talking with many other tech companies, including OpenAI and Elon Musk's SpaceX, to form a consortium to jointly bid on U.S. government contracts, The Financial Times reported Sunday. The aim is to take on traditional defense giants such as ( ), ( ), ( ) and ( ). Palantir and Anduril also reportedly are talking to Saronic and ScaleAI. Palantir and Anduril aim to announce a series of alliances next month, the FT said. Musk, as co-leader of President-elect Donald Trump's government efficiency drive, has signaled he will target Pentagon spending. He has specifically criticized the F-35 fighter jet as wasteful. Lockheed Martin makes the F-35, with Northrop Grumman a major sub-contractor. Boeing is a would-be competitor to SpaceX in private space fight. ( ) has soared since the election in the belief that the Trump administration will favor the EV giant. But there may be more scope for Trump to aid SpaceX, via defense and space government contracts. Palantir stock jumped 8.5% on Friday to 80.55, a record close. PLTR stock is by far the top performer in the S&P 500 index this year, up 369%.Incredible video shows Ukraine unleashing SHOTGUN-wielding drones to hunt down & blast Russians on frontline
You will bear all civil or criminal legal responsibilities directly or indirectly caused by your actions and speech.
Message board administrators have the right to retain or delete any content in the messages under their jurisdiction.
This site reminds: Do not make personal attacks. Thank you for your cooperation.
mcw casino apps login All rights reserved. Unauthorized reproduction, copying or mirroring is prohibited. Violators will be held accountable.
Statement: All information presented on this site is edited and published by the mcw casino apps login work team. Copyright is reserved. Plagiarism is strictly prohibited. Do not reproduce or mirror without authorization. Otherwise, this site reserves the right to pursue legal liability.
Copyright © 2018 Tencent. All Rights Reserved